Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FQV2L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $125,321
Award facts
- Contract value 100% obligated
- $125,321.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $125,321.25 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This firm fixed-price, non-set-aside contract was executed on January 22, 2026, with an ultimate completion date of January 23, 2026, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999.9 million through December 31, 2031, serving as the comprehensive vehicle for pharmaceutical and medical supply procurement to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company demonstrates extensive capability in fulfilling diverse pharmaceutical requirements through competitively awarded contracts with firm fixed pricing. As a subsidiary of Cencora, Inc., the company leverages the parent organization's substantial IDC to deliver a comprehensive range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26FQV2L?
SPE2DR26FQV2L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FQV2L worth?
The government has obligated $125,321 on SPE2DR26FQV2L.
Is contract SPE2DR26FQV2L an order under another contract?
Yes. SPE2DR26FQV2L is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQV2L competed?
The extent of competition for SPE2DR26FQV2L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award